Unilife Reports Financial Results and Significant Milestones

Posted by Laura Swartz

November 24, 2010 at 10:26 AM

Unilife Corp. (UNIS-NASDAQ) has recently announced its financial results for the three months ended September 30, 2010, which marked the end of the Company’s first quarter of fiscal 2011. During the quarter, Unilife continued to advance the industrialization program for its Unifill™ glass-barreled, prefilled safety syringe. The Company intends to move into a new global headquarters and production facility during December 2010. As a result, supply of the Unifill™ Syringe to sanofi-aventis SA (SNY-NYSE) could begin in early 2011 (one year ahead of schedule), with high-volume manufacturing likely to be in place by the end of 2011.

Read More

Topics: Newsworthy Events

Up to $1 Billion in New Credits/Grants for Healthcare

Posted by Laura Swartz

November 15, 2010 at 10:33 AM

As part of the Patient Protection and Affordable Care Act of 2010, Congress established a program known as the Qualifying Therapeutic Discovery Project (QTDP) to offer tax credits or grants for projects that show significant potential to produce new and cost-saving therapies, support jobs, and increase the U.S.’s competitiveness. Under the program, a total of $1 billion is allocated for credits and grants.

Read More

Topics: Newsworthy Events, Advaxis

Recent Financial Results and Corporate Updates

Posted by Colleen Koski

November 12, 2010 at 10:35 AM

Several companies within our Research Library this week reported financial results, including Pro-Pharmaceuticals, Inc. (PRWP-OTC), Authentidate Holding Corp. (ADAT-NASDAQ), Antares Pharma, Inc. (AIS-NYSE Amex), and Bioniche Life Sciences Inc. (BNC-TSX).

Read More

Topics: Newsworthy Events, Authentidate, Bioniche

New research available on Applied DNA Sciences

Posted by Laura Swartz

November 4, 2010 at 10:39 AM

After the close of the market today, we published an updated Executive Informational Overview on Applied DNA Sciences, Inc. (APDN-OTC.BB). Follow the jump for a brief overview of Applied DNA or visit our website at www.crystalra.com to access the full 68-page report at no charge. As well, join our mailing list to be notified of new future report releases.

Read More

Topics: New Research, Applied DNA Sciences

Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Topic